Effect of Exercise on MiR-126 in Individuals With Prediabetes
EMiR-126-PD
2 other identifiers
interventional
64
1 country
1
Brief Summary
This study aims to investigate the effect of a structured exercise program on microRNA-126 (miR-126) expression in individuals with prediabetes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2023
CompletedFirst Submitted
Initial submission to the registry
January 23, 2025
CompletedFirst Posted
Study publicly available on registry
February 5, 2025
CompletedFebruary 5, 2025
January 1, 2025
2 years
January 23, 2025
January 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Delta CT mir-126
Ct (cycle threshold) values for miR-126 and miR-16-5p were used for analysis. ΔCt and ΔΔCt values were calculated as follows, and expression levels were analyzed using the 2-ΔΔCt method: ∆Ct = Ct (gene of interest) - Ct (housekeeping gene) ΔΔCt = ∆Ct (treated sample) - ∆Ct (untreated sample) Higher ΔCt values indicate lower expression levels.
1 week
Secondary Outcomes (1)
BMI
1 day
Study Arms (2)
Exercise
ACTIVE COMPARATORIndividuals in the intervention group were included in a planned aerobic exercise program for 12 weeks.This program was carried out under the supervision of specialist doctors, with the help of sports trainers and physiotherapists, and participants were given 60 minutes of moderate-intensity (50-70% of their maximum heart rate) aerobic exercise three days a week.
Control
NO INTERVENTIONNo intervention
Interventions
Eligibility Criteria
You may qualify if:
- Individuals who were newly diagnosed with prediabetes according to the Oral Glucose Tolerance Test (OGTT) and/or HbA1C criteria
- between the ages of 18-60
- were physically inactive (Level 1 according to the International Physical Activity Questionnaire)
- were motivated to exercise
- Individuals who had no obstacle to exercise as a result of the evaluation made by a cardiologist (ECG, exercise ECG test, etc.)
- and who did not show a change in body weight of more than ±2.5 kg in the last six months were included in the study.
You may not qualify if:
- presence of serious medical conditions (e.g. advanced cancer, major neurological or endocrine disorders, respiratory failure)
- current cardiovascular disease, BMI \<19 kg/m²
- history of metformin use within the last 6 months
- receiving hormone replacement therapy
- life expectancy less than one year
- HIV positivity
- substance use
- or orthopedic and cognitive disorders that may prevent exercise
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sultan 2. Abdülhamid Han Training and Research Hospital
Üsküdar, Istanbul, 34660, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elif Yıldırım Ayaz
Sultan 2. Abdülhamid Han Training and Research Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof. Dr.
Study Record Dates
First Submitted
January 23, 2025
First Posted
February 5, 2025
Study Start
May 1, 2021
Primary Completion
April 30, 2023
Study Completion
April 30, 2023
Last Updated
February 5, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share